Thrombophilia found in patients with Moyamoya disease

Clinical Neurology and Neurosurgery

Volumn 99, Issue SUPPL. 2, 1997, Pages

  Tsuda, H ^a   Hattori, S ^a   Tanabe, S ^a   Nishioka, S ^a   Matsushima, T ^a   Ikezaki, K ^a   Fukui, M ^a   Kinoshita, S ^a   Hamasaki, N ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Moyamoya disease; Thrombophilia

Indexed keywords

ANTITHROMBIN III; FIBRINOGEN; LUPUS ANTICOAGULANT; PLASMINOGEN; PROTEIN C; PROTEIN S;

ADOLESCENT; ADULT; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; MALE; MOYAMOYA DISEASE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA;

EID: 0030703108     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0303-8467(97)00050-4     Document Type: Conference Paper

References (22)

1. Kudo T. Spontanious occlusion of the circle of Willis: A disease apparently confined to Japanese. Neurology. 18:1968;485-495.
2. Nishimoto A., Takeuchi S. Abnormal cerebrovascular network related to the internal carotid arteries. J Neurosurg. 29:1968;255-260.
3. Suzuki, J., Moyamoya Disease, Springer-Verlag, Berlin, 1983.
4. Kitamura K, Fukui M, Oka K, Matsushima T, Kurokawa T, Hasuo K, Moyamoya disease, In: Tool JF, editor. Handbook of Clinical Neurology. New York: Elsevier, 1989:293-306.
5. Hosoda Y. Pathology of so-called spontaneous occlusion of the circle of Willis. Pathol Annu. 19:1984;221-244.
6. Yonekawa Y, Goto Y, Ogata N, Moyamoya disease: diagnosis, treatment, and recent achievement, In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eidtors, Stroke: Pathophysiology, Diagnosis, And Management, 2nd ed. New York: Churchill Livingstone, 1992:721-47.
7. Hirsh J, Prins MH, Samama M, Approach to the thrombophilic patient for hemostasis and thrombosis: Basic principles and clinical practice, In: Colman RW, Hirsh J, Marder VJ, Salzman, editor. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd ed. Philadelphia: J.B. Lippincott, 1994:1543-61.
8. Rosenberg R.D., Rosenberg J.S. Natural anticoagulant mechanisms. J Clin Invest. 74:1984;1-6.
9. Rodgers G.M., Greenberg C.S., Shuman M.A. Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood. 61:1983;1155-1162.
10. Lane D.A., Mannucci P.M., Bauer K.A., Bertina R.M., Bochkov N.P., Boulyjenkov V., Chaudy M., Dahlbäck B., Ginter E.K., Miletich J.P., Rosendaal F.R., Seligsohn U. Inherited thrombophilia: Part 1. Thromb Haemost. 76:1996;651-662.
11. Feinstein D. Lupus anticoagulants, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus. Blood. 80:1992;859-862.
12. Yamashita M., Oka K., Tanaka K. Cervio-cephalic arterial thrombi and thromboemboli in Moyamoya disease: Possible correlation with progressive intimal thickening in the intracranial major arteries. Stroke. 15:1984;264-270.
13. Colaco C.B., Elkon K.B. The lupus anticoagulant: A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA. Arthritis Rheum. 28:1985;67-74.
14. Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem. 261:1986;12022-12027.
15. Aoki N., Tateno K., Sakata Y. Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: New methods for the detection of plasminogen variants. Biochem Genet. 22:1984;871-881.
16. Ichinose A., Espling E.S., Takamatsu J., Saito H., Shinmyozu K., Maruyama I., Petersen T.E., Davie E.W. Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci USA. 88:1991;115-119.
17. Vigano-D'Angelo S., D'Angelo A., Kaufman C.E., Sholer C., Esmon C.T., Comp P.C. Protein S deficiency occurs in the nephrotic syndrome. Ann Intern Med. 107:1987;42-47.
18. Aadland E., Ødegaard R., Røseth A., Try K. Free protein S deficiency in patients with Crohn's disease. Scand J Gastroenterol. 29:1994;333-335.
19. Parke A.L., Weinstein R.E., Bona R.D., Maier D.B., Walker F.J. The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S. Am J Med. 93:1992;49-56.
20. Chifu Y., Nakashima H., Hara T., Yokota E., Imamura T. β-Thalassemia major resulting from a compound heterozygosity for the β-globin gene mutation: further evidence for multiple origin and migration of the thalassemia gene. Hum Genet. 89:1992;343-346.
21. Yashar V.B., Barenholz Y., Hy-Am E., Rachmilewitz E.A., Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol. 44:1993;63-65.
22. Roubey R.A.S. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus aticoagulants and other 'antiphospholipd' autoantibodies. Blood. 84:1994;2854-2867.